Compounds > 6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride
Page last updated: 2024-09-03

6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride and 6-ketoprostaglandin f1 alpha

6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies

Compound Research Comparison

Studies
(6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride)		Trials
(6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride)		Recent Studies (post-2010)
(6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride)		Studies
(6-ketoprostaglandin f1 alpha)		Trials
(6-ketoprostaglandin f1 alpha)		Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha)
8004,832294150

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giessler, C; Heinroth-Hoffmann, I; Mest, HJ1

Other Studies

1 other study(ies) available for 6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride and 6-ketoprostaglandin f1 alpha

ArticleYear
Relevance of vasoactive mediators for the blood pressure effects of intravenous arachidonic acid injection in rats.
    Prostaglandins, leukotrienes, and essential fatty acids, 1992, Volume: 46, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Aspirin; Blood Pressure; Cyproheptadine; Diterpenes; Ginkgolides; Imidazoles; Injections, Intravenous; Lactones; Male; Naphthalenes; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane B2

1992